Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Prostate. 2019 May 2;79(10):1090–1098. doi: 10.1002/pros.23820

TABLE 1.

Characteristics of analytic sample at baseline (488 Matched Pairs)

Variable Response Cases Controls P value
Race* white 290 290
African American 198 198
Mean Age at cohort entry, y* 65.3 ± 7.4 65.4 ± 7.4
Date of 1st benign specimen*
Median 5/4/1995 4/12/1995
Range 1/19/90–11/25/02 1/18/90–9/30/02
Years to case diagnosis or follow-up time for controls*
Median 4.15 4.15
Range 1.01–15.09 1.01–15.09
Mean serum PSA at cohort entry, ng/mL 7.82 ± 7.40 5.91 ± 5.49 < 0.0001
Mean PSA velocity, ng/mL/year 7.97 ± 97.12 −0.06 ± 2.49 < 0.0001
Mean number of PSA tests from cohort entry to diagnosis (cases) or reference (controls) date 6.61 ± 3.56 5.55 ± 3.18 < 0.0001

Abbreviation: PSA, prostate-specific antigen.

**

Paired Wilcoxon Sign Rank Test

*

Matching variable.